Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{9bcef9ca45764de3b0e68cd0906e907b,
title = "Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort",
abstract = "OBJECTIVE: To investigate long-term pattern of mortality in menopausal women according to different modalities of hormone therapy.DESIGN: Population-based prospective cohort study.SETTING: Denmark 1993-2013.POPULATION: A total of 29 243 women aged 50-64 years at entry into the Diet, Cancer and Health Cohort, enrolled 1993-97 and followed through 31 December 2013.METHODS: Cox' proportional hazards models for increasingly longer periods of follow-up time were used to estimate mortality pattern according to baseline hormone use adjusted for relevant potential confounders.MAIN OUTCOME(S): All-cause and cause-specific mortality. Outcome information was obtained from the Danish Register of Causes of Death (linkage 99.6{\%}).RESULTS: A total of 4098 women died during a median follow up of 17.6 years. After adjustment for relevant lifestyle risk factors, hormone use had no impact on all-cause mortality, regardless of modality. Among baseline users, lower cardiovascluar disease mortality was only evident after 5 years [hazard ratio (HR) 0.54; 95{\%} CI 0.32-0.92], but dissipated with additional follow up. Conversely, lower colorectal cancer mortality (HR 0.64; 95{\%} CI 0.46-0.89) and higher breast cancer mortality (HR 1.34; 95{\%} CI 1.05-1.72) only became evident after 15 years of follow up. There were no significant associations for mortality from other types of cancer or from stroke.CONCLUSIONS: In this long-term follow-up study, taking hormones during menopause was not associated with overall mortality among middle-aged women. Investigating cause-specific mortality revealed significant, albeit weak, differential associations according to both causes of death and over time, underlining the importance of carefully considering individual risks and duration of treatment when making decisions on hormone therapy.TWEETABLE ABSTRACT: Long-term follow-up study confirms no association between menopausal hormone therapy and overall mortality.",
keywords = "all-cause mortality, cause-specific mortality, menopausal hormone therapy, time-varying mortality estimates",
author = "M Holm and A Olsen and {Au Yeung}, {S L} and K Overvad and {\O} Lidegaard and N Kroman and A Tj{\o}nneland",
note = "{\circledC} 2018 Royal College of Obstetricians and Gynaecologists.",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/1471-0528.15433",
language = "English",
volume = "126",
pages = "55--63",
journal = "BJOG: An International Journal of Obstetrics and Gynaecology",
issn = "1470-0328",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Pattern of mortality after menopausal hormone therapy

T2 - long-term follow up in a population-based cohort

AU - Holm, M

AU - Olsen, A

AU - Au Yeung, S L

AU - Overvad, K

AU - Lidegaard, Ø

AU - Kroman, N

AU - Tjønneland, A

N1 - © 2018 Royal College of Obstetricians and Gynaecologists.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - OBJECTIVE: To investigate long-term pattern of mortality in menopausal women according to different modalities of hormone therapy.DESIGN: Population-based prospective cohort study.SETTING: Denmark 1993-2013.POPULATION: A total of 29 243 women aged 50-64 years at entry into the Diet, Cancer and Health Cohort, enrolled 1993-97 and followed through 31 December 2013.METHODS: Cox' proportional hazards models for increasingly longer periods of follow-up time were used to estimate mortality pattern according to baseline hormone use adjusted for relevant potential confounders.MAIN OUTCOME(S): All-cause and cause-specific mortality. Outcome information was obtained from the Danish Register of Causes of Death (linkage 99.6%).RESULTS: A total of 4098 women died during a median follow up of 17.6 years. After adjustment for relevant lifestyle risk factors, hormone use had no impact on all-cause mortality, regardless of modality. Among baseline users, lower cardiovascluar disease mortality was only evident after 5 years [hazard ratio (HR) 0.54; 95% CI 0.32-0.92], but dissipated with additional follow up. Conversely, lower colorectal cancer mortality (HR 0.64; 95% CI 0.46-0.89) and higher breast cancer mortality (HR 1.34; 95% CI 1.05-1.72) only became evident after 15 years of follow up. There were no significant associations for mortality from other types of cancer or from stroke.CONCLUSIONS: In this long-term follow-up study, taking hormones during menopause was not associated with overall mortality among middle-aged women. Investigating cause-specific mortality revealed significant, albeit weak, differential associations according to both causes of death and over time, underlining the importance of carefully considering individual risks and duration of treatment when making decisions on hormone therapy.TWEETABLE ABSTRACT: Long-term follow-up study confirms no association between menopausal hormone therapy and overall mortality.

AB - OBJECTIVE: To investigate long-term pattern of mortality in menopausal women according to different modalities of hormone therapy.DESIGN: Population-based prospective cohort study.SETTING: Denmark 1993-2013.POPULATION: A total of 29 243 women aged 50-64 years at entry into the Diet, Cancer and Health Cohort, enrolled 1993-97 and followed through 31 December 2013.METHODS: Cox' proportional hazards models for increasingly longer periods of follow-up time were used to estimate mortality pattern according to baseline hormone use adjusted for relevant potential confounders.MAIN OUTCOME(S): All-cause and cause-specific mortality. Outcome information was obtained from the Danish Register of Causes of Death (linkage 99.6%).RESULTS: A total of 4098 women died during a median follow up of 17.6 years. After adjustment for relevant lifestyle risk factors, hormone use had no impact on all-cause mortality, regardless of modality. Among baseline users, lower cardiovascluar disease mortality was only evident after 5 years [hazard ratio (HR) 0.54; 95% CI 0.32-0.92], but dissipated with additional follow up. Conversely, lower colorectal cancer mortality (HR 0.64; 95% CI 0.46-0.89) and higher breast cancer mortality (HR 1.34; 95% CI 1.05-1.72) only became evident after 15 years of follow up. There were no significant associations for mortality from other types of cancer or from stroke.CONCLUSIONS: In this long-term follow-up study, taking hormones during menopause was not associated with overall mortality among middle-aged women. Investigating cause-specific mortality revealed significant, albeit weak, differential associations according to both causes of death and over time, underlining the importance of carefully considering individual risks and duration of treatment when making decisions on hormone therapy.TWEETABLE ABSTRACT: Long-term follow-up study confirms no association between menopausal hormone therapy and overall mortality.

KW - all-cause mortality

KW - cause-specific mortality

KW - menopausal hormone therapy

KW - time-varying mortality estimates

U2 - 10.1111/1471-0528.15433

DO - 10.1111/1471-0528.15433

M3 - Journal article

VL - 126

SP - 55

EP - 63

JO - BJOG: An International Journal of Obstetrics and Gynaecology

JF - BJOG: An International Journal of Obstetrics and Gynaecology

SN - 1470-0328

IS - 1

ER -

ID: 55854131